Showing results (11-20 of 81) with videos related to
Sort By:
Pageof 9
Journal of Drug Targeting|September 21, 2016
Recent trends in targeted therapy of cancer using graphene oxide-modified multifunctional nanomedicinesNazanin Rahmanian, Morteza Eskandani, Jaleh Barar, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 3, 2018
Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancerSomayeh Vandghanooni, Morteza Eskandani, Jaleh Barar, et al.Food Chemistry|February 5, 2014
Cytotoxicity and DNA damage properties of tert-butylhydroquinone (TBHQ) food additiveMorteza Eskandani, Hamed Hamishehkar, Jafar Ezzati Nazhad DolatabadiAssay and Drug Development Technologies|November 16, 2022
Silibinin-Loaded Nanostructured Lipid Carriers for Growth Inhibition of Cisplatin-Resistant Ovarian Cancer CellsSevda Jafari, Atabak Bakhshaei, Morteza Eskandani, et al.Nanomedicine (London, England)|November 6, 2018
AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cellsSomayeh Vandghanooni, Morteza Eskandani, Jaleh Barar, et al.Bioimpacts : BI|July 24, 2019
Aptamedicine: a new treatment modality in personalized cancer therapySomayeh Vandghanooni, Morteza Eskandani, Jaleh Barar, et al.International Journal of Pharmaceutics|November 10, 2019
Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cellsSomayeh Vandghanooni, Morteza Eskandani, Jaleh Barar, et al.Advanced Pharmaceutical Bulletin|August 2, 2016
Formulation and Physicochemical Characterization of Lycopene-Loaded Solid Lipid NanoparticlesElham Nazemiyeh, Morteza Eskandani, Hossein Sheikhloie, et al.Journal of Molecular Medicine (Berlin, Germany)|July 30, 2018
Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspectiveSomayeh Vandghanooni, Morteza Eskandani, Jaleh Barar, et al.International Journal of Pharmaceutics|July 18, 2025
From barriers to breakthroughs: Mesoporous silica nanoparticles in targeting the tumor microenvironmentAdel Mahmoudi Gharehbaba, Fatemeh Soltanmohammadi, Morteza Eskandani, et al.Pageof 9